We develop proprietary ocular biomarkers to revolutionise neurology care and drug development. Our collaborations with world-leading clinical and research organisations1 enable us to create state-of-the-art digital biomarker capture and analytics products.
: University of Oxford, University College London Hospitals, Guy's and St Thomas' Hospital, Queen Mary University
Get early access to our technology.Request a demo
Solvemed works with patients, healthcare providers and life sciences industry to establish the next level of care for people suffering from neurodegenerative disorders.